Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium

被引：0

作者：

Meagher, Nicola S. ^{[1
,2
]}

White, Kami K. ^{[3
]}

Wilkens, Lynne R. ^{[3
]}

Bandera, Elisa, V ^{[4
]}

Berchuck, Andrew ^{[5
]}

Carney, Michael E. ^{[6
]}

Cramer, Daniel W. ^{[7
,8
,9
]}

Cushing-Haugen, Kara L. ^{[10
]}

Jordan, Susan ^{[11
]}

Kaufmann, Scott H. ^{[12
,13
,14
]}

Le, Nhu D. ^{[15
]}

Pike, Malcolm C. ^{[16
,17
]}

Riggan, Marjorie ^{[5
]}

Qin, Bo ^{[4
]}

Rothstein, Joseph H. ^{[18
,19
]}

Titus, Linda ^{[20
]}

Winham, Stacey J. ^{[21
]}

Anton-Culver, Hoda ^{[22
]}

Doherty, Jennifer A. ^{[23
]}

Goode, Ellen L. ^{[24
]}

Pearce, Celeste Leigh ^{[25
]}

Risch, Harvey A. ^{[26
]}

Webb, Penelope M. ^{[27
]}

Cook, Linda S. ^{[28
,29
]}

Goodman, Marc T. ^{[30
]}

Harris, Holly R. ^{[10
,31
]}

Le Marchand, Loic ^{[32
]}

McGuire, Valerie ^{[33
]}

Pharoah, Paul D. P. ^{[34
,35
]}

Sarink, Danja ^{[3
]}

Schildkraut, Joellen M. ^{[36
]}

Sieh, Weiva ^{[18
,19
]}

Terry, Kathryn L. ^{[7
,8
,9
]}

Thompson, Pamela J. ^{[37
]}

Whittemore, Alice S. ^{[35
,38
]}

Wu, Anna H. ^{[17
]}

Peres, Lauren C. ^{[39
]}

Merritt, Melissa A. ^{[1
]}

机构：

[1] Univ Sydney, Daffodil Ctr, Joint Venture Canc Council NSW, Sydney, NSW, Australia

[2] Univ NSW Sydney, Sch Clin Med, UNSW Med & Hlth, Sydney, NSW, Australia

[3] Univ Hawaii, Canc Epidemiol Program, Canc Ctr, Honolulu, HI USA

[4] Rutgers Canc Inst New Jersey, Canc Prevent & Control Program, New Brunswick, NJ USA

[5] Duke Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Med Ctr, Durham, NC USA

[6] Univ Hawaii, John A Burns Sch Med, Dept Obstet & Gynecol, Honolulu, HI USA

[7] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA USA

[8] Harvard Med Sch, Boston, MA USA

[9] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[10] Fred Hutchinson Canc Ctr, Program Epidemiol, Div Publ Hlth Sci, Seattle, WA USA

[11] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia

[12] Mayo Clin, Dept Oncol, Rochester, MN USA

[13] Mayo Clin, Dept Pharmacol, Rochester, MN USA

[14] Mayo Clin, Dept Med, Rochester, MN USA

[15] BC Canc Res Ctr, Canc Control Res, Vancouver, BC, Canada

[16] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA

[17] Univ Southern Calif, Keck Sch Med, Dept Populat & Publ Hlth Sci, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[18] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA

[19] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY USA

[20] Univ Southern Maine, Muskie Sch Publ Serv, Publ Hlth, Portland, ME USA

[21] Mayo Clin, Dept Quantitat Hlth Sci, Div Computat Biol, Rochester, MN USA

[22] Univ Calif Irvine, Genet Epidemiol Res Inst, Dept Med, Irvine, CA USA

[23] Univ Utah, Huntsman Canc Inst, Dept Populat Hlth Sci, Salt Lake City, UT USA

[24] Mayo Clin, Dept Quantitat Hlth Sci, Div Epidemiol, Rochester, MN USA

[25] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI USA

[26] Yale Sch Publ Hlth, Chron Dis Epidemiol, New Haven, CT USA

[27] QIMR Berghofer Med Res Inst, Populat Hlth Program, Brisbane, Qld, Australia

[28] Univ Colorado, Sch Publ Hlth, Epidemiol, Aurora, CO USA

[29] Univ Calgary, Community Hlth Sci, Calgary, AB, Canada

[30] Cedars Sinai Med Ctr, Canc Prevent & Control Program, Los Angeles, CA USA

[31] Univ Washington, Dept Epidemiol, Seattle, WA USA

[32] Univ Hawaii, Epidemiol Program, Canc Ctr, Honolulu, HI USA

[33] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA USA

[34] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England

[35] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England

[36] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA

[37] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Canc Prevent & Genet Program, Los Angeles, CA USA

[38] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA USA

[39] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2024年 / 193卷 / 09期

基金：

美国国家卫生研究院; 澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;

关键词：

ovarian cancer; risk factors; race; ethnicity; POOLED ANALYSIS; SUBTYPES;

D O I：

10.1093/aje/kwae076

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Limited estimates exist on risk factors for epithelial ovarian cancer (EOC) in Asian, Hispanic, and Native Hawaiian/Pacific Islander women. Participants in this study included 1734 Asian (n = 785 case and 949 control participants), 266 Native Hawaiian/Pacific Islander (n = 99 case and 167 control participants), 1149 Hispanic (n = 505 case and 644 control participants), and 24 189 White (n = 9981 case and 14 208 control participants) from 11 studies in the Ovarian Cancer Association Consortium. Logistic regression models estimated odds ratios (ORs) and 95% CIs for risk associations by race and ethnicity. Heterogeneity in EOC risk associations by race and ethnicity (P <= .02) was observed for oral contraceptive (OC) use, parity, tubal ligation, and smoking. We observed inverse associations with EOC risk for OC use and parity across all groups; associations were strongest in Native Hawaiian/Pacific Islander and Asian women. The inverse association for tubal ligation with risk was most pronounced for Native Hawaiian/Pacific Islander participants (odds ratio (OR) = 0.25; 95% CI, 0.13-0.48) compared with Asian and White participants (OR = 0.68 [95% CI, 0.51-0.90] and OR = 0.78 [95% CI, 0.73-0.85], respectively). Differences in EOC risk factor associations were observed across racial and ethnic groups, which could be due, in part, to varying prevalence of EOC histotypes. Inclusion of greater diversity in future studies is essential to inform prevention strategies.This article is part of a Special Collection on Gynecological Cancers.

引用

页码：1242 / 1252

页数：11

共 50 条

[41] Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
Nagle, C. M.
Dixon, S. C.
Jensen, A.
Kjaer, S. K.
Modugno, F.
deFazio, A.
Fereday, S.
Hung, J.
Johnatty, S. E.
Fasching, P. A.
Beckmann, M. W.
Lambrechts, D.
Vergote, I.
Van Nieuwenhuysen, E.
Lambrechts, S.
Risch, H. A.
Rossing, M. A.
Doherty, J. A.
Wicklund, K. G.
Chang-Claude, J.
Goodman, M. T.
Ness, R. B.
Moysich, K.
Heitz, F.
du Bois, A.
Harter, P.
Schwaab, I.
Matsuo, K.
Hosono, S.
Goode, E. L.
Vierkant, R. A.
Larson, M. C.
Fridley, B. L.
Hogdall, C.
Schildkraut, J. M.
Weber, R. P.
Cramer, D. W.
Terry, K. L.
Bandera, E. V.
Paddock, L.
Rodriguez-Rodriguez, L.
Wentzensen, N.
Yang, H. P.
Brinton, L. A.
Lissowska, J.
Hogdall, E.
Lundvall, L.
Whittemore, A.
McGuire, V.
Sieh, W.
BRITISH JOURNAL OF CANCER, 2015, 113 (05) : 817 - 826
[42] History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
Minlikeeva, Albina N.
Freudenheim, Jo L.
Eng, Kevin H.
Cannioto, Rikki A.
Friel, Grace
Szender, J. Brian
Segal, Brahm
Odunsi, Kunle
Mayor, Paul
Diergaarde, Brenda
Zsiros, Emese
Kelemen, Linda E.
Kobel, Martin
Steed, Helen
deFazio, Anna
Jordan, Susan J.
Fasching, Peter A.
Beckmann, Matthias W.
Risch, Harvey A.
Rossing, Mary Anne
Doherty, Jennifer A.
Chang-Claude, Jenny
Goodman, Marc T.
Doerk, Thilo
Edwards, Robert
Modugno, Francesmary
Ness, Roberta B.
Matsuo, Keitaro
Mizuno, Mika
Karlan, Beth Y.
Goode, Ellen L.
Kjaer, Susanne K.
Hogdall, Estrid
Schildkraut, Joellen M.
Terry, Kathryn L.
Cramer, Daniel W.
Bandera, Elisa V.
Paddock, Lisa E.
Kiemeney, Lambertus A.
Massuger, Leon F. A. G.
Sutphen, Rebecca
Anton-Culver, Hoda
Ziogas, Argyrios
Menon, Usha
Gayther, Simon A.
Ramus, Susan J.
Gentry-Maharaj, Aleksandra
Pearce, Celeste L.
Wu, Anna H.
Kupryjanczyk, Jolanta
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (09) : 1470 - 1473
[43] Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
C M Nagle
S C Dixon
A Jensen
S K Kjaer
F Modugno
A deFazio
S Fereday
J Hung
S E Johnatty
P A Fasching
M W Beckmann
D Lambrechts
I Vergote
E Van Nieuwenhuysen
S Lambrechts
H A Risch
M A Rossing
J A Doherty
K G Wicklund
J Chang-Claude
M T Goodman
R B Ness
K Moysich
F Heitz
A du Bois
P Harter
I Schwaab
K Matsuo
S Hosono
E L Goode
R A Vierkant
M C Larson
B L Fridley
C Høgdall
J M Schildkraut
R P Weber
D W Cramer
K L Terry
E V Bandera
L Paddock
L Rodriguez-Rodriguez
N Wentzensen
H P Yang
L A Brinton
J Lissowska
E Høgdall
L Lundvall
A Whittemore
V McGuire
W Sieh
British Journal of Cancer, 2015, 113 : 817 - 826
[44] Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
Pearce, C. L.
Wu, A. H.
Gayther, S. A.
Bale, A. E.
Beck, P. A.
Beesley, J.
Chanock, S.
Cramer, D. W.
DiCioccio, R.
Edwards, R.
Fredericksen, Z. S.
Garcia-Closas, M.
Goode, E. L.
Green, A. C.
Hartmann, L. C.
Hogdall, E.
Kjaer, S. K.
Lissowska, J.
McGuire, V.
Modugno, F.
Moysich, K.
Ness, R. B.
Ramus, S. J.
Risch, H. A.
Sellers, T. A.
Song, H.
Stram, D. O.
Terry, K. L.
Webb, P. M.
Whiteman, D. C.
Whittemore, A. S.
Zheng, W.
Pharoah, P. D. P.
Chenevix-Trench, G.
Pike, M. C.
Schildkraut, J.
Berchuck, A.
BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 282 - 288
[45] Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
C L Pearce
A H Wu
S A Gayther
A E Bale
P A Beck
J Beesley
S Chanock
D W Cramer
R DiCioccio
R Edwards
Z S Fredericksen
M Garcia-Closas
E L Goode
A C Green
L C Hartmann
E Hogdall
S K Kjær
J Lissowska
V McGuire
F Modugno
K Moysich
R B Ness
S J Ramus
H A Risch
T A Sellers
H Song
D O Stram
K L Terry
P M Webb
D C Whiteman
A S Whittemore
W Zheng
P D P Pharoah
G Chenevix-Trench
M C Pike
J Schildkraut
A Berchuck
British Journal of Cancer, 2008, 98 : 282 - 288
[46] Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium EDITORIAL COMMENT
Trabert, Britton
Poole, Elizabeth M.
White, Emily
Visvanathan, Kala
Adami, Hans-Olov
Anderson, Garnet L.
Brasky, Theodore M.
Brinton, Louise A.
Fortner, Renee T.
Gaudet, Mia
Hartge, Patricia
Hoffman-Bolton, Judith
Jones, Michael
Lacey, James V., Jr.
Larsson, Susanna C.
Mackenzie, Gerardo G.
Schouten, Leo J.
Sandler, Dale P.
O'Brien, Katie
Patel, Alpa V.
Peters, Ulrike
Prizment, Anna
Robien, Kim
Setiawan, Wendy V.
Swerdlow, Anthony
van den Brandt, Piet A.
Weiderpass, Elisabete
Wilkens, Lynne R.
Wolk, Alicja
Wentzensen, Nicolas
Tworoger, Shelley S.
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (10) : 576 - 578
[47] Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Dixon, Suzanne C.
Nagle, Christina M.
Wentzensen, Nicolas
Trabert, Britton
Beeghly-Fadiel, Alicia
Schildkraut, Joellen M.
Moysich, Kirsten
deFazio, Anna
Risch, Harvey A.
Rossing, Mary Anne
Doherty, Jennifer A.
Wicklund, Kristine G.
Goodman, Marc T.
Modugno, Francesmary
Ness, Roberta B.
Edwards, Robert P.
Jensen, Allan
Kjaer, Susanne K.
Hogdall, Estrid
Berchuck, Andrew
Cramer, Daniel W.
Terry, Kathryn L.
Poole, Elizabeth M.
Bandera, Elisa V.
Paddock, Lisa E.
Anton-Culver, Hoda
Ziogas, Argyrios
Menon, Usha
Gayther, Simon A.
Ramus, Susan J.
Gentry-Maharaj, Aleksandra
Pearce, Celeste Leigh
Wu, Anna H.
Pike, Malcolm C.
Webb, Penelope M.
BRITISH JOURNAL OF CANCER, 2017, 116 (09) : 1223 - 1228
[48] Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium
Suzanne C Dixon
Christina M Nagle
Nicolas Wentzensen
Britton Trabert
Alicia Beeghly-Fadiel
Joellen M Schildkraut
Kirsten B Moysich
Anna deFazio
Harvey A Risch
Mary Anne Rossing
Jennifer A Doherty
Kristine G Wicklund
Marc T Goodman
Francesmary Modugno
Roberta B Ness
Robert P Edwards
Allan Jensen
Susanne K Kjær
Estrid Høgdall
Andrew Berchuck
Daniel W Cramer
Kathryn L Terry
Elizabeth M Poole
Elisa V Bandera
Lisa E Paddock
Hoda Anton-Culver
Argyrios Ziogas
Usha Menon
Simon A Gayther
Susan J Ramus
Aleksandra Gentry-Maharaj
Celeste Leigh Pearce
Anna H Wu
Malcolm C Pike
Penelope M Webb
British Journal of Cancer, 2017, 116 : 1223 - 1228
[49] Racial/ethnic disparities in ovarian cancer research
Peres, Lauren C.
Schildkraut, Joellen M.
CANCER HEALTH EQUITY RESEARCH, 2020, 146 : 1 - 21
[50] Racial/ethnic disparities in ovarian cancer survival
Khanna, N.
Hu, J.
Allen, G.
Clarke, J.
Lucci, J.
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S114 - S114

← 1 2 3 4 5 →